These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3572975)
21. Preparation and antibacterial activity of delta 1-thienamycin. Shih DH; Ratcliffe RW J Med Chem; 1981 May; 24(5):639-43. PubMed ID: 7241525 [TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationship for antibacterial action of phenolic and aromatic nitro compounds. An attempt at systematic identification of new antibacterial agents. Oikawa S; Tsuda M; Endou K; Abe H; Matsuoka M; Nakajima Y Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2821-31. PubMed ID: 4085041 [No Abstract] [Full Text] [Related]
23. Synthesis and antibacterial activity of some novel 6-methyl- and 6-propenyl-substituted carbapenems. Mastalerz H; Menard M; Ruediger E; Fung-Tomc J J Med Chem; 1992 Mar; 35(5):953-8. PubMed ID: 1548685 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, antibacterial activity and structure-activity relationships of N-substituted 3-methyl-4-diazo-5-pyrazolecarboxamides. Baraldi PG; Brigidi P; Casolari A; Manfredini S; Periotto V; Recanatini M; Roberti M; Rossi M Arzneimittelforschung; 1989 Nov; 39(11):1406-10. PubMed ID: 2619772 [TBL] [Abstract][Full Text] [Related]
25. Formal synthesis of Thienamycin. Pieczykolan M; Furman B; Chmielewski M J Antibiot (Tokyo); 2017 Jun; 70(6):781-787. PubMed ID: 28377636 [TBL] [Abstract][Full Text] [Related]
26. Chemical modification of carbapenem antibiotics. Versatile methods for displacement of the C-3 sulfur side chain of carbapenems with other thiol groups. Yamamoto K; Yoshioka T; Kato Y; Isshiki K; Nishino M; Nakamura F; Shimauchi Y; Ishikura T J Antibiot (Tokyo); 1983 Apr; 36(4):407-15. PubMed ID: 6853369 [No Abstract] [Full Text] [Related]
27. Modification of the cysteamine side chain of thienamycin. II. Sato M; Takemura M; Atarashi S; Higashi K; Fujiwara H; Nagahara T; Furukawa M; Ikeuchi T; Ozawa S; Nishizawa N J Antibiot (Tokyo); 1987 Apr; 40(4):483-95. PubMed ID: 3583917 [TBL] [Abstract][Full Text] [Related]
28. Pyrrolnitrin analogues. IX. Synthesis and biological activity of 1-tolyl-3-nitrophenyl-5-methylpyrazole-4-carboxylic acids and 1-tolyl-3-methyl-5-nitrophenylpyrazole-4-carboxylic acids. Cecchi L; Melani F; Palazzino G; Filacchioni G; Porretta GC Farmaco Sci; 1984 Oct; 39(10):888-900. PubMed ID: 6510520 [TBL] [Abstract][Full Text] [Related]
37. Kinetic analysis of dehydropeptidase-I and comparative in vitro and in vivo stabilities of PS-5 derivatives modified at the C-3 side chain. Sakamoto M; Yamamoto K; Isshiki K; Tone H; Ishikura T; Fukagawa Y; Yoshioka T Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):341-8. PubMed ID: 2054858 [TBL] [Abstract][Full Text] [Related]
38. Semisynthetic coumermycins. VI. Preparation and properties of 3-(3-aryl- and 3-aralkyl-4-hydroxybenzamido)-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl)noviosyloxy]coumarins. Schmitz H; Godfrey JC J Antibiot (Tokyo); 1970 Oct; 23(10):497-501. PubMed ID: 5482760 [No Abstract] [Full Text] [Related]
39. Syntheses and antimicrobial activities of 3-acyltetramic acid derivatives. Matsuo K; Kimura M; Kinuta T; Takai N; Tanaka K Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4197-204. PubMed ID: 6529815 [No Abstract] [Full Text] [Related]